Antimicrobial Drug Use and Changes in Resistance in Streptococcus pneumoniae | CMAC

Antimicrobial Drug Use and Changes in Resistance in Streptococcus pneumoniae

Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):126-132

​ Diekema D.J., Brueggemann A.B., Doern G.V.
pneumococci chemotherapy antibiotic resistance pharmacoepidemiology
Section
Antimicrobial Resistance
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):126-132

Abstract

Translated and reprinted with permission from «Emerging Infectious Diseases» 2000; 6:552-6.

Resistance of Streptococcus pneumoniae to antimicrobial drug is increasing. To investigate the relationship between antimicrobial use and susceptibility of S.pneumoniae isolates at 24 U.S. medical centers, we obtained data on outpatient antimicrobial-drug use for the regions surrounding 23 of these centers. We found an association between decreased penicillin susceptibility and use of b-lactam antimicrobial drugs.

  • 1. Butler J.C., Hofmann J., Cetron M.S., Elliott J.A., Facklam R.R., Breiman R.F. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention’s pneumococcal sentinel surveillance system. J Infect Dis 1996;174:986-93.
  • 2. Doern G.V., Pfaller M.A., Kugler K., Freeman J., Jones R.N. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis 1998;27:764-70.
  • 3. Munoz R., Coffey T.J., Daniels M., Dowson C.G., Laible G., Casal J., et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991;164:302-6.
  • 4. Reichler M.R., Rakovsky J., Sobotova A., Slacikova M., Hiavacova B., Hill B., et al. Multiple antimicrobial resistance of pneumococci in children with otitis media, bacteremia, and meningitis in Slovakia. J Infect Dis 1995; 171:1491-6.
  • 5. Laible G., Spratt B.G., Hakenbeck R. Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Mol Microbiol 1991;5:1993-2002A
  • 6. Arnold K.E., Leggiadro R.J., Breiman R.F., Lipman H.B., Schwartz B., Appleton M.A., et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among Memphis, Tennessee, children. J Pediatr 1996;128:757-64.
  • 7. Bedos J.P., Chevret S., Chastang C., Geslin P., Regnier B., and the French Cooperative Pneumococcus Study Group. Epidemiologic features of and risk factors for infection by Streptococcus pneumoniae with diminished susceptibility to penicillin: findings of a French survey. Clin Infect Dis 1996;22:63-72.
  • 8. Duchin J.S., Breiman R.F., Diamond A., Lipman H.B., Block S.L., Hedrick J.A., et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995;14:745-50.
  • 9. Ford K.L., Mason E.O., Kaplan S.L., Lamberth L., Tillman J. Factors associated with middle ear isolates of Streptococcus pneumoniae resistant to penicillin in a children’s hospital. J Pediatr 1991;119:941-4.
  • 10. Nava J.M., Bella F., Garau J., Lite J., Morera M.A., Marti C., et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994;19:884-90.
  • 11. Pallares R., Gudiol F., Linares J., Ariza J., Rufi G., Margui L., et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987;317:18-22.
  • 12. Reichler M.R., Allphin A.A., Breiman R.F., Schreiber J.R., Arnold J.E., McDougal L.K., et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-53.
  • 13. Tan T.Q., Mason’ S.O., Kaplan S.L. Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics 1993;92:761-7.
  • 14. Scares S., Kristinsson K.G., Musser J.M., Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980’s. J Infect Dis 1993;168:158-63.
  • 15. Welby P.L., Keller D.S., Cromien J.L., Tebas P., Storch G. Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children’s hospital. Pediatr Infect Dis 1994;13:281-7.
  • 16. Doern G.V., Brueggemann A., Holley H.P., Rauch A.M. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40:1208-13.
  • 17. Doern G.V., Brueggemann A.B., Huynh H., Wingert E., Rhomberg P. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98. Emerg Infect Dis 1999;5:757-65.
  • 18. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. Wayne (PA): National Committee for Clinical Laboratory Standards; 1997.
  • 19. Performance standards for antimicrobial susceptibility testing. Supplemental tables, M100-S8. Wayne (PA): National Committee for Clinical Laboratory Standards; 1998.
  • 20. Healthwire B.W. IMS Health annual data show expanding pharmaceutical market growth. Biomed Pharmacother 1999; 53:290-2.
  • 21. Gaynes R. The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am 1997;11:757-65.
  • 22. Gerding D.N., Larson Т.А. Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967-1985. Am J Med 1986;80: 22-8.
  • 23. McGowan J.E. Antimicrobial resistance in hospital, organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-48.
  • 24. Monnet D., Gaynes R., Tenover F., McGowan J.E., ICARE Pilot Hospitals. Ceftazidime-resistant Pseudomonas aeruginosa and ceftazidime usage in NNIS hospitals: preliminary results of Project ICARE, Phase one. Infect Control Hosp Epidemiol 1995;4(Suppl):19.
  • 25. Muscat J.J., Wilbur D.W., Stout J.J., Fahriender R.A. An evaluation of the susceptibility patterns of gram-negative organisms isolated in cancer centers with aminoglycoside usage. J Antimicrob Chemother 1991;27(Suppl C):l-7.
  • 26. Pradier C., Dunais B., Carsenti-Etesse H., Dellamonica P. Pneumococcal resistance patterns in Europe. Eur J Clin Microbiol Infect Dis 1997;16:644-7.
  • 27. Nowak R. Hungary sees an improvement in penicillin resistance. Science 1994;264:364.
  • 28. Kristinsson К.С. Epidemiology of penicillin-resistant pneumococci. Nord Med 1996;111:103-8.
  • 29. Gonzales R., Steiner J.F., Sande M.A. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997;278:901-4.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared